Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-12-017356
Filing Date
2012-12-11
Accepted
2012-12-11 21:06:48
Documents
2
Period of Report
2012-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 6948
2 POWER OF ATTORNEY ex-24.txt EX-24 4055
  Complete submission text file 0001179110-12-017356.txt   12491
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Oncothyreon Inc. (Issuer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 0612
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O ONCOTHYREON INC. 2601 FOURTH AVE, SUITE 500 SEATTLE WA 98121
Business Address
PETERSON SCOTT ROBERT (Reporting) CIK: 0001563986 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33882 | Film No.: 121257655